Combined inhibition of lysine-specific demethylase 1 and kinase signaling as a preclinical treatment strategy in glioblastoma
Lea Stitzlein(The University of Texas MD Anderson Cancer Center), Joya Chandra(The University of Texas MD Anderson Cancer Center), Huaxian Ma, Frederick F. Lang(The University of Texas MD Anderson Cancer Center), Wafik Zaky(The University of Texas MD Anderson Cancer Center), Richard W. Dudley(University of Findlay), Kareena H. Patel(The University of Texas MD Anderson Cancer Center), Gangadhara R. Sareddy(The University of Texas at San Antonio Health Science Center), Joy Gumin(The University of Texas MD Anderson Cancer Center), Oren J. Becher(Icahn School of Medicine at Mount Sinai), Jing Wang(Sun Yat-sen University), Heping Wang(First Bethune Hospital of Jilin University), Deokhwa Nam(The University of Texas MD Anderson Cancer Center), Faith A Hernandez(The University of Texas MD Anderson Cancer Center), Katie Impelman(The University of Texas MD Anderson Cancer Center), Alaina Poche(The University of Texas MD Anderson Cancer Center), Samantha Gadd(Northwestern University)
Cited by 0
Related Papers
Pediatric high-grade glioma: biologically and clinically in need of new thinking
|Neuro-Oncology|2016|365
Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications
|Acta Neuropathologica|2014|357
Neuron-Derived Estrogen Regulates Synaptic Plasticity and Memory
|Journal of Neuroscience|2019|222